AI is everywhere in radiology—but is it actually making imaging better for clinicians and patients? In this interview, Dr. Ravi Bikram Shrestha, General Manager & Sr. Director of Global Healthcare IT at Canon Medical…
Continue Reading
Timely detection of atrial fibrillation (AF) is crucial for the prevention of serious consequences such as stroke and heart failure, yet it remains challenging due to its often asymptomatic or paroxysmal nature. Wearable devices…
Continue Reading
Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round.The round was co-led by existing investors Parkwalk Advisors and the Boehringer…
Continue Reading
In this case study, PocDoc, an alumnus of DigitalHealth.London’s Accelerator programme, shares how they are enabling people to test their cholesterol from home and spot the early signs of cardiovascular diseases.PocDoc was developed with…
Continue Reading
Demonstrating cardiovascular (CV) benefits with lipid-lowering therapy (LLT) requires long-term randomized clinical trials (RCTs) with thousands of patients. Innovative approaches such as in silico trials applying a disease computational model to virtual patients receiving…
Continue Reading
Digital therapeutic software firm Strolll has secured £10.35m for its augmented reality (AR) glasses to help people living with neurological disorders such as Parkinson’s disease, stroke and multiple sclerosis.
The Series A funding round was…
Approximately half of the adults in the United States (116 million) have high blood pressure, or hypertension, with 91.7 million needing prescription medication in addition to lifestyle changes. As of 2017, the self-reported prevalence…
Continue Reading
What You Should Know:
– Philips, a global leader in health technology, today announced a partnership with the World Bank and Ukraine’s Ministry of Health (MOH) to modernize stroke and cardiovascular care across Ukraine.
– The…
Continue Reading
A study led by researchers at Oxford Population Health identified 28% more cases of atrial fibrillation in primary care data than secondary care data alone.
Evidence of atrial fibrillation, which is associated with higher risks…
Endovascular treatment (EVT) for vertebrobasilar artery occlusion (VBAO) with atrial fibrillation presents complex clinical challenges. This comprehensive multicenter study of 525 patients across 15 Chinese provinces investigated nuanced predictors beyond conventional metrics. While 45.1%…
Continue Reading
